Skip to main content
. Author manuscript; available in PMC: 2022 Jul 22.
Published in final edited form as: Stem Cell Res. 2021 Apr 8;53:102342. doi: 10.1016/j.scr.2021.102342

1. Resource Table.

Unique stem cell identifier FDCHDPe010-A-56

Alternative name(s) of stem cell line LRP2-KO hESCs
Institution Eye & ENT Hospital, Shanghai Medical School, Fudan University, Shanghai, China
Contact information of distributor Jie You, 513yj45@163.com;
Ling Chen, linglingchen98@hotmail.com
Type of cell line ESC
Origin Human
Additional origin info Age: blastocyst stage
Sex: female, 46, XX
Ethnicity: N/A
Cell source N/A
Clonality Clonal
Method of reprogramming N/A
Cell culture system used mTeSR™1
Genetic modification Yes
Type of modification Induced mutation
Associated disease Endocytosis deficiency disease
Gene/locus Gene:LRP2
Locus:2q31.1
Method of modification CRISPR/Cas9
Site-specific nuclease (SSN) delivery method Plasmid transfection
All genetic material introduced into the cells Cas plasmid
Karyotyping
Analysis of the nuclease- targeted allele status
Method of the off-target nuclease activity surveillance Targeted PCR/sequencing
Name of transgene or resistance N/A
Inducible/constitutive system Transient expression of Sacas9 and GFP under CMV promoter
Data archived/stock date December 2020
Cell line repository/bank N/A
Ethical approval This study was approved by the ethics committee of Fudan University affiliated Eye & ENT Hospital (KJ2011-04)